Federal Register / Vol. 87, No. 8 / Wednesday, January 12, 2022 / Notices 1767 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Assay 

Validation of High-Quality Markers for 

Clinical Studies in Cancer (UH2/UH3). 

Date: March 9, 2022. 

Time: 9:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W634, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Michael E. Lindquist, 

Ph.D., Scientific Review Officer, Research 

Programs, Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W634, Rockville, Maryland 20850, 

mike.lindquist@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–2A: 

SBIR Contract Review Meeting. 

Date: March 10, 2022. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W264, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Ombretta Salvucci, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609, Medical 

Center Drive, Room 7W264, Rockville, 

Maryland 20850, 240–276–7286, salvucco@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–8: NCI 

Clinical and Translational Cancer Research. 

Date: March 10–11, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W126, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Susan Lynn Spence, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W126, Rockville, Maryland 

20850, 240–620–0819, susan.spence@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–2B: 

SBIR Contract Review Meeting. 

Date: March 11, 2022. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W264, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Ombretta Salvucci, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W264, Rockville, 

Maryland 20850, 240–276–7286, salvucco@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–6: 

SBIR Contract Review Meeting. 

Date: March 15–16, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W114, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Jeffrey E. DeClue, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W114, Rockville, Maryland 

20850, 240–276–6371, decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Coordinating Center (U24) and Program (R01) 

on the Origins of Gastroesophageal Cancers. 

Date: March 17, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W248, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Anita T. Tandle, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W248, 

Rockville, Maryland 20850, 240–276–5085, 

tandlea@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Pancreatic Cancer Detection Consortium 

U01/U24. 

Date: March 17, 2022. 

Time: 12:30 p.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W244, Rockville, Maryland 20850, 

(Telephone Conference Call). 

Contact Person: John Paul Cairns, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W244, 

Rockville, Maryland 20850, 240–276–5415, 

paul.cairns@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–7: 

SBIR Contract Review Meeting. 

Date: March 18, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W260, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Nadeem Khan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W260, Rockville, Maryland 

20850, 240–276–5856, nadeem.khan@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–5: 

SBIR Contract Review Meeting. 

Date: March 23, 2022. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W106, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Eduardo Emilio Chufan, 

Ph.D., Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W106, Rockville, Maryland 

20850, 240–276–7975, chufanee@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–12: 

SBIR Contract Review Meeting. 

Date: April 5, 2022. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W102, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Shakeel Ahmad, Ph.D., 

Branch Chief, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W102, Rockville, Maryland 20850, 

240–276–6442, ahmads@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 6, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–00433 Filed 1–11–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 


lotter on DSK11XQN23PROD with NOTICES1
1768 Federal Register / Vol. 87, No. 8 / Wednesday, January 12, 2022 / Notices 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; GeroscienceBased Chronic Wound Treatment. 

Date: February 4, 2022. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Birgit Neuhuber, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, National 

Institutes of Health, 7201 Wisconsin Avenue, 

Gateway Building, Suite 2W200, Bethesda, 

MD 20892, 301–480–1266, neuhuber@

ninds.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: January 7, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–00486 Filed 1–11–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Review of Data Analysis 

R03 Applications. 

Date: February 9, 2022. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: NIDCR, 6701 Democracy Boulevard, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Yun Mei, MD, Scientific 

Review Officer, Scientific Review Branch, 

Natl Institute of Dental and Craniofacial 

Research, National Institutes of Health, 6701 

Democracy Boulevard, Suite #670, Bethesda, 

MD 20892, (301) 827–4639, yun.mei@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: January 6, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–00430 Filed 1–11–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory Dental 

and Craniofacial Research Council. 

The meeting will be held as a virtual 

meeting and is open to the public. 

Individuals who plan to view the virtual 

meeting and need special assistance or 

other reasonable accommodations, 

should notify the Contact Person listed 

below in advance of the meeting. The 

open session will be videocast and can 

be accessed from the NIH Videocasting 

and Podcasting website (http://

videocast.nih.gov). 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Dental and Craniofacial Research Council. 

Date: January 25, 2022. 

Open: 10:00 a.m. to 2:15 p.m. 

Agenda: Report of the Director, NIDCR and 

concept clearances. 

Place: National Institutes of Health, 6701 

Democracy Blvd., Bethesda, MD 20892 

(Virtual Meeting). 

Closed: 2:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Democracy Blvd., Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Lynn M. King, Ph.D., 

Director, Division of Extramural Research, 

National Institute of Dental and Craniofacial 

Research, 6701 Democracy Blvd., Room 960, 

Bethesda, MD 20892–4878, 301–594–5006, 

Lynn.King@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.nidcr.nih.gov/about, where an agenda 

and any additional information for the 

meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: January 6, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–00435 Filed 1–11–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Collaborative Applications: Clinical Studies 

of Mental Illness (Collaborative R01). 

Date: February 8, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 


lotter on DSK11XQN23PROD with NOTICES1